Fact CheckerSign in

NCT05750095Recruiting

Enabling Parents of Children With Autism Spectrum Disorders - a Randomized Controlled Trial of Parenting Programs

Source: ClinicalTrials.gov · Last updated 18 Mar 2026

Brief summary (registry, in English)

Autism spectrum disorders (ASD) are disabling and impairing conditions affecting 1% of children in Norway. ASD is hallmarked by severe social deficit and lack of independence causing reliance on supportive systems throughout life. Parents are usually the primary caretakers and support, often throughout life. Normal parenting skills are however often ineffective due to the social dysfunction of the child with ASD. This causes high stress as the demands exceed the resources and capability of the parent. The high stress is associated to increased risk for mental health problems, divorce, unemployment and reduced quality of life. High parent stress may also reduce the effect of interventions in ASD. However, although the need is great and parental follow-up is an integral part of health care for ASD children, there is a lack of evidence for such interventions. The current project aims to evaluate a specific parent program that is in clinical use - the Incredible Years for children with ASD - compared with a standardised treatment as usual (TAU) composed of clinical parent workshops ("first aid for parents"). The aim is to evaluate parenting interventions and promote evidence-based practice in a clinical setting. The investigators will perform a randomized controlled trial and qualitative interviews to compare the effectiveness of treatment as usual (TAU) versus a manualized parent program (IY-ASLD). The study aims to investigate if the parental program may reduce parent stress and improve parental competence and self-efficacy. Secondary goals are to investigate whether the parent program may improve quality of life for the parent and the child and have an impact on long-term child functioning and service use.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
240 (estimated)
First submitted
26 Jan 2023
Start date
10 Jan 2022
Primary completion date
30 Oct 2028
Lead sponsor
Haukeland University Hospital
Diseases
Autism
NCT number
NCT05750095

What you commit to

  • Study type: Interventional
  • Planned participants: 240
  • From 10 Jan 2022 to the primary completion date, 30 Oct 2028
  • 3 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Ongoing major crisis in the family or major disabling condition in the participating parent

Other

  • Level of Norwegian insufficient to benefit from a parental program without the use of an interpreter
  • Ongoing participation in another manualized (any) parent program

Who the study is looking for

  • Parent of child diagnosed with an autism spectrum disorder, age 2-6

Age in the registry: 2 years to 6 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (3)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Haukeland University Hospital
Coordinator of this site? Confirm its status
BergenNorwayRecruiting
Helse Fonna
Coordinator of this site? Confirm its status
HaugesundNorwayRecruiting
St Olavs Hospital
Coordinator of this site? Confirm its status
TrondheimNorwayRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.